It is one of the fastest for a brand-new drug type, and that speaks to how seriously obesity is being taken as a public health crisis
Both Mounjaro and Zepbound feature tirzepatide, a dual agonist for GLP-1 and GIP receptors
Part 3: The GLP-1 Friendly Lifestyle Strategy To thrive on these medications, you need a protocol that prioritizes muscle defense
This medications safety profile has not been studied in patients under the age of 18, pregnant and lactating people, or those with normal BMIs. At the time of publishing, the FDA has only approved three GLP-1 agonists for weight loss: Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide)
Other Ways to Access GLP-1 Treatments If your insurance appeals dont work out, there are still alternative ways to access GLP-1 treatments